B. Riley raised the firm’s price target on InfuSystem (INFU) to $14 from $13 and keeps a Buy rating on the shares following the Q3 report.
B. Riley raised the firm’s price target on InfuSystem (INFU) to $14 from $13 and keeps a Buy rating on the shares following the Q3 report.